Creative

PreciseDx® is innovating oncology diagnostics, leveraging Artificial Intelligence (AI) for revolutionary, morphology-driven disease analysis. Combining AI with their patented Morphology Feature Array® (MFA), PreciseDx provides highly accurate, actionable intelligence and disease insights that support better decision-making throughout the cancer care continuum.